Meet the providers and experts taking a Cologuard®- first approach
What is a Cologuard1st?
Cologuard1sts are experts and healthcare leaders who advocate for the Cologuard test to their average-risk patients 45 years and older first and reserve colonoscopy for the patients who need it most.
Meet the Cologuard1sts
Dr Christine Molmenti | PhD, MPH
A nationally recognized cancer epidemiologist and associate professor, Dr Molmenti leads groundbreaking research in CRC prevention, with a focus on CRC in women and early-onset disease. She plays a key role in shaping strategy and scientific direction across several major research institutes.
Widely respected for her leadership and expertise, she spearheads multi-institutional collaborations, advances screening equity, and mentors emerging public health professionals committed to driving impact at scale.
“Early onset CRC is a growing public health issue, and we need tools younger patients will actually use. The Cologuard test provides a solution—a simple, preferred first step that helps us catch CRC earlier in a population that is often resistant to colonoscopy. I’m a Cologuard1st because I see how this simple test can drive massive impact—for individual patients and at a public health level”6-8
Dr Christine Molmenti | PhD, MPH
Provider has been compensated for sharing her expertise and consulting for Exact Sciences.
Provider has been compensated for sharing her expertise and consulting for Exact Sciences.
Wendy L. Wright | FNP
A dual-certified nurse practitioner and clinical leader, Wendy brings decades of experience to primary care, advanced practice, and health innovation. She leads an independent clinical practice and holds senior leadership roles across healthcare and technology sectors.
A nationally recognized speaker, educator, and advocate for nurse practitioner leadership, she advances independent practice, mentors clinicians nationwide, and contributes expert insight on clinical standards and quality of care.
“The Cologuard test has been around for over a decade, and it’s only getting better. That kind of track record builds trust for me and my patients. We had a patient, just 45, and her Cologuard result was positive. It turned out to be stage I rectal cancer. No radiation needed. That story fuels everything I do and that’s why I'm a Cologuard1st.”9,10
Wendy L. Wright | FNP
Dr Chuck Vega | MD
With over 20 years of experience at a Federally Qualified Health Center, Dr Vega is dedicated to bringing education and expanding access to quality care for underserved communities.
Passionate about driving change, he focuses on training future leaders to promote high-quality, compassionate, and accessible care for all.
“The Cologuard test’s strong performance, high patient adherence, and ability to detect advanced precancerous lesions help reduce unnecessary colonoscopies while ensuring those who need further evaluation get it. When patients understand their options and hear from a trusted voice, they’re more likely to follow through — improving outcomes and preventing more cases of CRC before they start.” 1-5
Dr Chuck Vega | MD
Provider has been compensated for sharing his expertise and consulting for Exact Sciences.
Provider has been compensated for sharing her expertise and consulting for Exact Sciences.
Belinda Khou | PA
A dedicated family medicine and urgent care provider, Belinda delivers chronic, acute, and preventive care to diverse populations.
Passionate about health equity, she empowers patients to make meaningful lifestyle changes to improve long-term health.
“I believe in the Cologuard test. It has helped more of my patients get screened by providing a reliable, noninvasive option they can complete at home. Many of my patients are more likely to adhere to screening when it fits into their lives, and the 3-year interval has really helped my patients adhere to testing. Early detection saves lives, and having a high-quality, patient-friendly test like the Cologuard test increases the chances of catching CRC sooner—when it’s most treatable.” 1-3,6,12
Belinda Khou | PA
Dr James Schultz | MD
Working in a Federally Qualified Health Center, Dr Schultz has served many patients facing issues with access and complications of undocumented status.
Drawing on his extensive experience expanding clinical operations and improving access to specialty care, he strives to remove barriers and improve access to care through leadership, advocacy, and innovation.
“With limited GI availability in my practice area, our health center generally does not refer patients to screening colonoscopy. The Cologuard test has made CRC screening more accessible to patients. With the additional support that comes with the Cologuard test, it’s eased the burden on our staff, making it easier to reach national screening goals and take meaningful steps toward closing the screening gap in our community.”13,14
Dr James Schultz | MD
Provider volunteered his expertise.
Patient Navigation Program
Explore our robust patient support program
CRC=colorectal cancer; GI=gastroenterologist.